What is Biolase Inc?
, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally.
BIOLQ · Verdict
Moderate reward · elevated risk
BIOLQ stands out on volatility and growth, but watch the profitability signal.
Based on 88% data coverage
BIOLQ · Verdict
Above average
Rev +29.2% CAGR · earnings +7.0%
Above average
-42% net margin · -1241% ROE
-31% free-cash-flow margin
Current ratio 1.26
Model-based scoring. For information only — not financial advice.
, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 3.66K.
The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.